Fleming K, Ashcroft A, Alexakis C, Tzias D, Groves C, Poullis A. Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
World J Gastroenterol 2015;
21:3376-3379. [PMID:
25805947 PMCID:
PMC4363770 DOI:
10.3748/wjg.v21.i11.3376]
[Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2014] [Revised: 10/25/2014] [Accepted: 12/01/2014] [Indexed: 02/06/2023] Open
Abstract
Five-amino salicylic acids are recommended for use in the management of inflammatory bowel disease, cardiac complications are a rare although recognised phenomenon. This report aims to highlight this serious but rare adverse reaction. We report here a case of a young man presenting with cardiogenic shock in the context of recent mesalazine treatment in severe ulcerative colitis.
Collapse